Gemcitabine and doxorubicin in immunostimulatory monophosphoryl lipid A liposomes for treating breast cancer-Reference-Cited by-同舟云学术

Gemcitabine and doxorubicin in immunostimulatory monophosphoryl lipid A liposomes for treating breast cancer

Published:2020-09-16 Issue:1 Volume:6 Page:
ISSN:2380-6761
Container-title:Bioengineering & Translational Medicine
language:en
Short-container-title:Bioeng Transl Med

Author:

Wu Debra¹²,Zhao Zongmin¹²,Kim Jayoung¹²,Razmi Amaya¹,Wang Lily Li‐Wen¹²³,Kapate Neha¹²³^ORCID,Gao Yongsheng¹²,Peng Kevin¹²,Ukidve Anvay¹²,Mitragotri Samir¹²^ORCID

Affiliation:

1. John A. Paulson School of Engineering and Applied Sciences Harvard University Cambridge Massachusetts USA

2. Wyss Institute of Biologically Inspired Engineering Harvard University Boston Massachusetts USA

3. Harvard‐MIT Division of Health Sciences and Technology Massachusetts Institute of Technology Cambridge Massachusetts USA

Funder

Harvard School of Engineering and Applied Sciences

Publisher

Wiley

Subject

Pharmaceutical Science,Biomedical Engineering,Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/btm2.10188

Reference54 articles.

1. Role of immune-checkpoint inhibitors in lung cancer

2. Biomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment—A Review From the Melanoma Perspective and Beyond

3. Immunotherapeutics for breast cancer

4. If we build it they will come: targeting the immune response to breast cancer

5. Immune Tumor Microenvironment in Breast Cancer and the Participation of Estrogen and Its Receptors in Cancer Physiopathology

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liposomes-enabled cancer chemoimmunotherapy;Biomaterials;2025-02

2. Ubiquitin ligase TRIM15 promotes the progression of pancreatic cancer via the upregulation of the IGF2BP2-TLR4 axis;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-06

3. Lipid-based nanomedicines for cancer immunotherapy;Nanomedicine in Cancer Immunotherapy;2024

4. Pluronic modified PLA based hybrid block copolymeric nanoformulation enhanced anti-cancer therapeutic efficacy of Epirubicin;European Polymer Journal;2023-07

5. TLR4 Agonist MPLA Ameliorates Heavy-Ion Radiation Damage via Regulating DNA Damage Repair and Apoptosis;Radiation Research;2023-06-06